Stage IV ALK Lung Cancer: Amanda's Patient Story
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Biomarkers
- ALK-rearranged
- Sex
- Female
- Spread to
- pleural fluid, right clavicle lymph node
- Treatment
- targeted therapy
- Outcome
- Living With Cancer
Treatment course, step by step
- ALK-targeted oral therapy, 8 pills daily; exact drug name not stated.
- Chemotherapy, radiation and surgery were discussed only as the patient’s initial expectation, not as treatments received in the available source.
What happened, in summary
Amanda was diagnosed with Stage IV ALK-positive lung cancer 10 days after giving birth to twins. During pregnancy, she had a high heart rate, low energy and a cough that doctors attributed to pregnancy. After delivery, the cough did not go away. She went to the emergency room just days after a C-section, still caring for newborn twins, and a chest X-ray showed fluid around her lung. A lung tap drained about 1 liter of fluid, and pathology later showed cancer cells. She also had a swollen right clavicle lymph node that she could feel. Amanda initially thought lung cancer treatment meant chemotherapy, radiation or surgery. Her oncologist changed that outlook by explaining biomarker testing and targeted therapy. Because she was young, her doctor suspected a mutation, and testing came back ALK-positive. That result allowed her to start ALK-targeted oral therapy rather than chemotherapy. The exact drug name was not stated, but Amanda said she takes 8 pills a day. As of December 2024, Amanda had lived with Stage IV lung cancer for about 2 years. She remained on daily targeted therapy, balancing hope with realism and advocating against the misconception that only smokers or older people get lung cancer.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer